A material which is used to verify the performance of an assay intended to be used for the qualitative and/or quantitative detection of glycated haemoglobin (HbA1c), also known as glycosylated haemoglobin, in a clinical specimen.
| Company | Devices | Share |
|---|---|---|
| Bio-Rad Laboratories, Inc. | 23 | 26% |
| Horiba Instruments Incorporated | 8 | 9% |
| Microgenics Corporation | 5 | 6% |
| Abbott Diagnostics Technologies As | 4 | 4% |
| Randox Laboratories Limited | 4 | 4% |
| Vitalscientific | 4 | 4% |
| Diazyme Laboratories, Inc. | 4 | 4% |
| Aalto Scientific | 4 | 4% |
| Wuxi Biohermes Bio & Medical Technology Co.,Ltd. | 3 | 3% |
| Primus Corporation | 3 | 3% |
| Lgc Clinical Diagnostics, Inc. | 3 | 3% |
| Streck, Inc. | 3 | 3% |
Company = labeler of record on GUDID. 27 companies in total; top 12 shown. Click headers to sort.
Sample of brand names as labelled; no endorsement. Ask us for the full list with company, model and UDI.
| Code | Name | Devices |
|---|---|---|
| JJX | Single (Specified) Analyte Controls (Assayed And Unassayed) | 28 |
| JJX | Single (specified) analyte controls (assayed and unassayed) | 13 |
| LCP | Assay, Glycosylated Hemoglobin | 11 |
| GGM | Control, hemoglobin | 8 |
| GGM | CONTROL, HEMOGLOBIN | 8 |
| LCP | ASSAY, GLYCOSYLATED HEMOGLOBIN | 4 |
Use these as the dimensions to specify in a tender line.
89 device records in commercial distribution are listed on the FDA Global Unique Device Identification Database (GUDID) under the GMDN category "Glycated haemoglobin (HbA1c) IVD, control", from 27 companies. The largest labeler is Bio-Rad Laboratories, Inc. with 26% of records.
JJX (Single (Specified) Analyte Controls (Assayed And Unassayed)), JJX (Single (specified) analyte controls (assayed and unassayed)), LCP (Assay, Glycosylated Hemoglobin), GGM (Control, hemoglobin)
No. GUDID is the US register. For the UAE (MOHAP/DoH) and Saudi (SFDA/MDMA) a separate registration and a local authorised representative are required; Consulting Wallah can check the status and connect you with registered suppliers.
Add glycated haemoglobin (hba1c) ivd, control to the RFQ basket or use the form below with quantity, specification and delivery location; the Network returns comparable quotes from verified suppliers in 2–5 working days.
Hospitals, pharmacies and distributors anywhere: tell us what you need and the Consulting Wallah Network returns comparable quotes from verified suppliers. No fee for buyers.
Source: FDA AccessGUDID (AccessGUDID full release 2 Nov 2026); counts are device records in commercial distribution grouped by GMDN preferred term; companies are labelers of record. Information only — US listing is not a registration in the UAE or GCC; verify with the regulator. © Consulting Wallah — CC BY‑NC‑ND.